Our mission is to become the global leader in prescription veterinary phytopharmaceuticals through the combination of:
Artificial intelligence
Pharmaceutical Science
Veterinary Medicine
Clinical Research
Regulatory Excellence
Our proprietary discovery platform, PolyNexis+™, enables the identification and optimisation of novel multi-compound therapeutics designed to address significant unmet needs in animal health.
Unlike traditional veterinary supplements or wellness products, our focus is on the development of regulatory-approved prescription medicines suitable for inclusion within veterinary prescribing pathways.
Our Vision
To become the preferred innovation partner for the global animal health industry through the development of next-generation veterinary therapeutics.
Our Values
Innovation
Applying artificial intelligence and pharmaceutical science to transform animal health.
One Health
Supporting the wellbeing of animals, owners and the wider environment.
Scientific Integrity
Developing therapies supported by rigorous clinical evidence and regulatory standards.
Collaboration
Partnering with veterinarians, regulators, academia and industry to advance veterinary medicine.
Our Team
Our experienced corporate and medical team comprises pharmaceutical industry experience, veterinary knowledge, and commercial excellence.
Professor Isaac Odeyemi
Chief Scientific Officer
Simon Hill
Chairman & Founder
Dr. Mike Anson
Executive Director in CMC Product Development at GSK